{"id":"W4205632236","doi":"10.1177/17588359211059601","title":"Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline <i>BRCA1</i> / <i>2</i> mutations and hormone receptor status from the phase-3 BROCADE3 trial","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Medical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Aptitude Health; AbbVie","keywords":"Hazard ratio; Veliparib; Breast cancer; Metastatic breast cancer; Clinical endpoint; Placebo; BRCA mutation; Germline mutation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001786605,0.000838923,0.002153897,0.0002978733,0.0002306659,0.001003654,0.0006348145,0.0008021738,0.001620614],"category_scores_gemma":[0.001620148,0.0003250975,0.002499695,0.0003947649,0.0004640002,0.00048338,0.0002550213,0.001564303,0.000248897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005996727,"about_ca_system_score_gemma":0.000824848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000496249,"about_ca_topic_score_gemma":0.001392885,"domain_scores_codex":[0.9992956,0.0004262662,0.00006167787,0.00009676944,0.00005278416,0.00006688343],"domain_scores_gemma":[0.9992959,0.0002141927,0.0002277989,0.00006906028,0.00003744044,0.0001555539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9552673,0.002228612,0.006232963,0.0005914138,0.005364366,0.00008066934,0.00006329219,0.001099889,0.005407739,0.00006170651,0.0006522577,0.02294971],"study_design_scores_gemma":[0.8795748,0.08207787,0.02671492,0.0001035135,0.006329554,0.0002231437,0.00006909953,0.001761495,0.001614676,0.0003299577,0.001164288,0.00003673809],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904196,0.007325177,0.0002680342,0.0003059482,0.00008760022,0.000445225,0.0004044606,0.00002731004,0.0007166102],"genre_scores_gemma":[0.996927,0.001375817,0.0002453297,0.0002770559,0.0001067336,0.0002593361,0.0005256619,0.000008520642,0.0002746763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002153897,"threshold_uncertainty_score":0.009448588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.026685671906535,"score_gpt":0.392095379246344,"score_spread":0.365409707339809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}